صنعتی کیمیدارو
دکیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 78,310 2.60
Close Price: 78,250
Cash Flow
AGM
Interim
2026/04/18 Fiscal Year 2025/12/2112 Month / Audited | 2026/03/25 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | -648.774 Billion | -617.515 Billion | |
Income Taxes Paid | -35.722 Billion | -35.722 Billion | |
Net Cash Flow from Operating Activities | -684.496 Billion | -653.237 Billion | |
Purchases of Property, Plant and Equipment | -50.097 Billion | -50.097 Billion | |
Purchases of Intangible Assets | -495 Million | -495 Million | |
Dividends Received | 570 Billion | 570 Billion | |
Cash Received from Income on Other Investments | 5.192 Billion | 5.192 Billion | |
Net Cash Flow from Investing Activities | 524.6 Billion | 524.6 Billion | |
Net Cash Flow before Financing Activities | -159.896 Billion | -128.637 Billion | |
Proceeds from Sale of Treasury Shares | 31.259 Billion | - | |
Cash Received from Borrowings | 4.71 Trillion | 4.71 Trillion | |
Repayments of Borrowings (Principal) | -3.705 Trillion | -3.705 Trillion | |
Interest Paid on Borrowings | -389.348 Billion | -389.348 Billion | |
Dividends Paid | -422.113 Billion | -422.113 Billion | |
Net Cash Flow from Financing Activities | 224.423 Billion | 193.164 Billion | |
Net Increase (Decrease) in Cash | 64.527 Billion | 64.527 Billion | |
Cash at Beginning of Period | 113.594 Billion | 113.594 Billion | |
Effect of Exchange Rate Changes | 14.503 Billion | 14.503 Billion | |
Cash at End of Period | 128.097 Billion | 128.097 Billion |